Return
Letter: The Promotion of Lemborexant in Patients With Liver Cirrhosis and Insomnia—Limitations of Population Generalisation and Liver Safety
W
Y
Y
DOI:10.1111/apt.70901.png)
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
A
IF:
6.7
Papers:
422
Citations:
0
